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Sir,
Limbic encephalitis (LE) is an autoimmune disorder which
can be of paraneoplastic or non-paraneoplastic origin.
Antibodies (Abs) against voltage-gated potassium channels
(VGKC-Abs) have recently been reported to be a possible
cause of non-paraneoplastic LE responding to immuno-
suppressive therapy [1–3]. However, this type of LE may
affect more than the limbic-restricted region, since some
cases are described with a rapidly progressing cortical
atrophy [2, 4].
A 79-year-old man was admitted to our hospital because
of auditory hallucinations, agitation, and confusion with
spatiotemporal disorientation. Neurological examination
was otherwise normal. His medical history included surgery
for epidermoid cancer of the left lung 5 years earlier which
was considered in complete remission according to onco-
logical investigations. At admission, blood serologies for
viruses and Lyme disease were negative. Paraneoplastic
Abs including anti-GAD, -Hu, -Ri, -YO, -CV2/CRMP,
-Amphiphysin, and -Ma2 were negative. Anti-phospholipid
Abs including anti-cardiolipin, anti-beta 2 glycoprotein, and
lupus anticoagulant were negative. In addition, Protein C
and S, antithrombine activity, and activated protein C
resistance were normal; factor V Leiden and factor II
mutations were absent. A CSF analysis revealed 50 WBC/
mm3, elevated proteins to 0.83 g/L and oligoclonal bands
matched in the serum. Serum VGKC-Abs were present at a
high titer of 3,495 pM (normal range: 0–100, Radioimmuno
assay detecting Kv1.1, 1.2 and 1.6 subtypes, laboratory of
Prof. A. Vincent, Oxford, UK). There was no electromyo-
graphic sign of neuromyotonia, his Na level was normal in
the serum and there was no antecedent of recent infective
illness. The cerebral MRI at admission (Fig. 1a) showed a
left hippocampus lesion with increased signal on coronal
FLAIR sequences. Axial gradient echo T2-weighted MRI
sequences showed the presence of cerebral microbleeds
(CMBs) in cortical and subcortical regions which dramati-
cally increased in number and size in the follow-up MRI
performed 14 weeks later (Fig. 1b, c, f, g). This accumu-
lation of CMBs was associated with signs of acute cortical
necrosis which correlated with progressive brain atrophy
(Fig. 1d, e, h, i). The clinical follow-up was characterized
by partial seizures with secondary generalization, which
required introduction of levetiracetam, as well as the
development of memory impairment and aphasia (encoding
ability 5 words: normal; verbal testing: 3/5 words immediate
recall and 0/5 words 10 min later; visual testing: 2/5 objects
immediate recall and 0/5 objects 10 min later; language
testing revealed mostly a motor aphasia with alteration of
the verbal fluency and some difficulties in comprehension of
complex verbal orders). Clinical symptoms were eventually
stabilized after high doses of IV corticosteroids and plasma
exchanges (5 courses) were initiated (auditory hallucina-
tions and agitation disappeared, but spatiotemporal disori-
entation, difficulties in comprehension of complex verbal
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orders and memory impairment persisted), which correlated
with a decrease of VGKC-Abs to 359 pM.
Interestingly, follow-up MRI revealed that some patients
with VGKC-Abs-associated LE may present with rapidly
progressing cerebral atrophy that exceed the temporal lobes
[2, 4]. It is nevertheless unclear from the recent literature
whether specific MRI sequences able to detect CMBs were
carried out or not on these patients. The MRI follow-up of
our patient is in accordance with these previous observa-
tions as witnessed by a global decline in cerebral volume
over 14 weeks. Gradient echo T2-weighted MRI sequences
showed CMBs which fulfilled the radiological criteria of
the Microbleed Study Group [5]. The significant increase
of cortical CMBs over this short period of time correlated
with signs of acute cortical necrosis. Thus, cortical CMBs
might be at the origin of the rapid and diffuse cortical
atrophy seen in some patients with VGKC-Ab-associated
encephalitis.
CMBs are often described in association with hyper-
tensive vasculopathy or cerebral amyloid angiopathy [5].
Hypertensive vasculopathy is typically associated with
CMBs in the basal ganglia, thalamus, brainstem and the
cerebellum [6], whereas cerebral amyloid angiopathy is
commonly associated with a lobar distribution of CMBs
[6, 7]. Since our patient had no history of high blood
pressure and CMBs were exclusively detected in lobar
areas, amyloid angiopathy could explain the presence of
the cortical CMBs.
Auto-Abs such as anti-phospholipid Abs may also cause
CMBs. In our patient these Abs were tested negative.
Interestingly, a recent histopathological report of a patient
with anti-VGKC encephalitis describes the presence of
parenchymal and perivascular B cells, supporting the
possibility of a humoral-mediated disease process [9]. In
this regard, an alternative hypothesis could imply a direct
link between VGKC-Abs and CMBs: K? channels are
highly expressed in vascular smooth muscle and endothe-
lial cells in the microcirculation of tissues, including the
blood brain barrier, and play an important role in the
vascular homeostasis [8]. Thus, it could be hypothesized
that VGKC-Abs bind to K? channels in the brain cortical
microvessels and induce a perturbation of vascular
homeostasis leading to vasoconstriction, which in turn may
provoke CMBs, necrosis, and progressive atrophy. Never-
theless, this hypothesis will require further investigations to
be confirmed.
In conclusion, our observation suggests that the presence
of CMBs should be explored in patients with VGKC-Ab-
Fig. 1 Brain MRI at admission (a–c), 8 weeks (d), and 14 weeks
(e–i) after admission. Increased signal and enlarged left hippocampus
on coronal FLAIR image (a, arrow). Axial gradient echo T2-weighted
MRI sequences showed the presence of few CMBs in cortical and
subcortical regions (b, c, arrows) which dramatically increased in
number and size in the follow-up MRI performed 14 weeks later
(f, g, arrows). This accumulation of CMBs correlated with the
progressive cortico-subcortical atrophy seen 14 weeks after admis-
sion (e, arrowheads). Signs of acute necrosis were detected in T1-
weighted sequences in the right parietal cortical region 8 weeks (d,
arrows) and 14 weeks (h, arrows) after admission. Areas of necrosis
were also diffusely detected in other regions including the right
temporal lobe and the thalamus (i, arrows)
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associated LE using appropriate MRI sequences. Con-
versely, patients presenting a rapid increase of CMBs
without a clear origin could be tested for VGKC-Abs.
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